Samer Somi

1.1k total citations
13 papers, 362 citations indexed

About

Samer Somi is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Samer Somi has authored 13 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 9 papers in Cardiology and Cardiovascular Medicine and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Samer Somi's work include Coronary Interventions and Diagnostics (13 papers), Cardiac Valve Diseases and Treatments (7 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). Samer Somi is often cited by papers focused on Coronary Interventions and Diagnostics (13 papers), Cardiac Valve Diseases and Treatments (7 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). Samer Somi collaborates with scholars based in Netherlands, Belgium and Germany. Samer Somi's co-authors include Clemens von Birgelen, Gerard C.M. Linssen, Peter W. Danse, Carine J.M. Doggen, Paolo Zocca, Carl E. Schotborgh, Marc Hartmann, Martin G. Stoel, K. Gert van Houwelingen and Marlies M. Kok and has published in prestigious journals such as The Lancet, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Samer Somi

13 papers receiving 357 citations

Peers

Samer Somi
Martijn Scholte Netherlands
Rosaly A. Buiten Netherlands
Elie Gharib United States
Paolo Zocca Netherlands
Jerome Williams United States
Igal Moarof Switzerland
Martijn Scholte Netherlands
Samer Somi
Citations per year, relative to Samer Somi Samer Somi (= 1×) peers Martijn Scholte

Countries citing papers authored by Samer Somi

Since Specialization
Citations

This map shows the geographic impact of Samer Somi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samer Somi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samer Somi more than expected).

Fields of papers citing papers by Samer Somi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samer Somi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samer Somi. The network helps show where Samer Somi may publish in the future.

Co-authorship network of co-authors of Samer Somi

This figure shows the co-authorship network connecting the top 25 collaborators of Samer Somi. A scholar is included among the top collaborators of Samer Somi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samer Somi. Samer Somi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Vlaar, Pieter J., J.P. van Kuijk, Maarten A. Vink, et al.. (2023). Bifurcation PCI with a hybrid strategy with drug- eluting balloons versus a stepwise provisional two- stent strategy: Rationale and design of the hybrid DEB study. American Heart Journal. 266. 168–175. 4 indexed citations
2.
Ploumen, Eline H., Rosaly A. Buiten, Paolo Zocca, et al.. (2022). Final 5‐Year Report of the Randomized BIO‐RESORT Trial Comparing 3 Contemporary Drug‐Eluting Stents in All‐Comers. Journal of the American Heart Association. 11(22). e026041–e026041. 15 indexed citations
3.
Ploumen, Eline H., Rosaly A. Buiten, Paolo Zocca, et al.. (2021). Acute myocardial infarction treated with novel Resolute Onyx and Orsiro stents in the randomized BIONYX trial. Catheterization and Cardiovascular Interventions. 98(2). E188–E196. 4 indexed citations
4.
Schampaert, Érick, Gautam Kumar, Stephan Achenbach, et al.. (2020). A global registry of fractional flow reserve (FFR)–guided management during routine care: Study design, baseline characteristics and outcomes of invasive management. Catheterization and Cardiovascular Interventions. 96(4). E423–E431. 7 indexed citations
5.
Buiten, Rosaly A., Eline H. Ploumen, Paolo Zocca, et al.. (2020). Thin Composite-Wire-Strut Zotarolimus-Eluting Stents Versus Ultrathin-Strut Sirolimus-Eluting Stents in BIONYX at 2 Years. JACC: Cardiovascular Interventions. 13(9). 1100–1109. 25 indexed citations
6.
Buiten, Rosaly A., Eline H. Ploumen, Paolo Zocca, et al.. (2019). Thin, Very Thin, or Ultrathin Strut Biodegradable or Durable Polymer-Coated Drug-Eluting Stents. JACC: Cardiovascular Interventions. 12(17). 1650–1660. 40 indexed citations
7.
Sukiennik, Adam, Daniel Weilenmann, Samer Somi, et al.. (2018). TCT-470 Worldwide Everyday Practice Registry Assessing the Xposition S Self-apposing Stent in Challenging Lesions with Vessel Diameter Variance (SIZING Registry). Journal of the American College of Cardiology. 72(13). B189–B189. 2 indexed citations
9.
Kauer, Floris, et al.. (2017). TCT-749 Worldwide every-day practice registry assessing the Xposition S Self-Apposing stent in challenging lesions with vessel diameter variance (SIZING registry). Journal of the American College of Cardiology. 70(18). B317–B317. 1 indexed citations
12.
Remkes, Wouter, Samer Somi, Vincent Roolvink, et al.. (2014). Direct Drug-Eluting Stenting to Reduce Stent Restenosis. JACC: Cardiovascular Interventions. 7(7). 751–758. 6 indexed citations
13.
Remkes, Wouter, Samer Somi, Vincent Roolvink, et al.. (2013). A comparison of 2 second generation drug eluting stents (Zotarolimus versus Everolimus), in elective PCI patients. European Heart Journal. 34(suppl 1). P3028–P3028. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026